Publicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (20)

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

    Autophagy, Vol. 12, Núm. 1, pp. 1-222

2000

  1. Pulmonary hypoplasia in the myogenin null mouse embryo

    American Journal of Respiratory Cell and Molecular Biology, Vol. 22, Núm. 3, pp. 304-315

1997

  1. Bcl-2 inhibits p53 nuclear import following DNA damage

    Oncogene, Vol. 15, Núm. 23, pp. 2767-2772

  2. bcl-2 expression confers androgen independence in androgen sensitive prostatic carcinoma

    International Journal of Oncology, Vol. 10, Núm. 1, pp. 113-118

1996

  1. Apoptosis suppression by bcl-2 is correlated with the regulation of nuclear and cytosolic Ca2+

    Oncogene, Vol. 12, Núm. 11, pp. 2259-2266

  2. Corrigendum: Combination adriamycin and suramin induces apoptosis in bcl-2 expressing prostate carcinoma cells (Cancer Letters (1995) 93 (147-155))

    Cancer Letters

  3. Expression of human immunodeficiency virus type I tat results in downregulation of bcl-2 and induction of apoptosis in hematopoietic cells

    Oncogene, Vol. 13, Núm. 3, pp. 487-493

  4. Regulation of cell death during multistep carcinogenesis

    Biochemical Society Transactions, Vol. 24, Núm. 4

  5. Tumor suppression and apoptosis of human prostate carcinoma mediated by a genetic locus within human chromosome 10pter-q11

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 93, Núm. 6, pp. 2551-2556

1995

  1. Cell death regulation during multistep lymphomagenesis

    Cancer Letters, Vol. 94, Núm. 1, pp. 17-23

  2. Combination adriamycin and suramin induces apoptosis in bcl-2 expressing prostate carcinoma cells

    Cancer Letters, Vol. 93, Núm. 2, pp. 147-155

  3. Differential regulation of endogenous endonuclease activation in isolated murine fibroblast nuclei by ras and bcl-2

    Oncogene, Vol. 10, Núm. 4, pp. 769-774

  4. Evidence that c-myc mediated apoptosis does not require wild-type p53 during lymphomagenesis

    Oncogene, Vol. 11, Núm. 1, pp. 175-179

  5. The Functional Basis of c-myc and bcl-2 Complementation during Multistep Lymphomagenesis in Vivo

    Experimental Cell Research, Vol. 217, Núm. 2, pp. 240-247

1994

  1. Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblasts to tumor necrosis factor: Induction of bcl-2, c-myc, and manganese superoxide dismutase in resistant cells

    Oncogene, Vol. 9, Núm. 7, pp. 2009-2017

  2. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis

    Oncogene, Vol. 9, Núm. 11, pp. 3107-3112

  3. Expression of bcl-2 gene confers multidrug resistance to chemotherapy- induced cell death

    Cancer Bulletin, Vol. 46, Núm. 2, pp. 125-129

1993

  1. The bcl-2 oncogene: Apoptosis and neoplasia

    Radiation Research

1992

  1. Differential expression of the neu oncogene in mouse liver and pancreatic cell lines

    Biochemical and Biophysical Research Communications, Vol. 186, Núm. 1, pp. 363-370